Remdesivir & COVID Studies Find Different Results

South Africa News News

Remdesivir & COVID Studies Find Different Results
South Africa Latest News,South Africa Headlines
  • 📰 WebMD
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 51%

Two new reports have produced conflicting results on the potential effectiveness of remdesivir, an experimental antiviral drug considered to be one of the leading hopes in the fight against COVID-19. What you need to know:

In the study from China, 237 severely ill patients were randomly chosen to receive either remdesivir or abetween Feb. 6 and March 12 at 10 hospitals in Hubei, the province that includes Wuhan. Researchers had aimed to recruit 453 patients, but a steep decline in COVID-19 cases prevented them from reaching that goal.

The early results reported Wednesday by Gilead are based on an initial phase of the U.S.-led clinical trial involving 397 patients with severe COVID-19 assigned to receive either 5 or 10 days of remdesivir. There was no mention of a control or placebo group. More than 64% of the patients who received the shorter treatment course were discharged, compared with 54% of the group treated for 10 days.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

WebMD /  🏆 709. in US

South Africa Latest News, South Africa Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Gilead Sciences says there are 'positive data' from a study on possible Covid-19 treatment remdesivirGilead Sciences says there are 'positive data' from a study on possible Covid-19 treatment remdesivirThere's 'positive data' emerging from a study on possible Covid-19 treatment remdesivir, the maker of the investigational drug says
Read more »

Gilead says remdesivir shows improvement in COVID-19 patients when used earlyGilead says remdesivir shows improvement in COVID-19 patients when used earlyGilead Sciences Inc on Wednesday said its experimental antiviral drug remdesivir helped improve outcomes for patients with COVID-19, and provided data suggesting it worked better when given earlier in the course of infection.
Read more »

NYT: US planning emergency use of Gilead's remdesivir in COVID-19 - Business InsiderNYT: US planning emergency use of Gilead's remdesivir in COVID-19 - Business InsiderUS health authorities are reportedly preparing to allow emergency use of Gilead's antiviral remdesivir to treat coronavirus patients, following positive study results
Read more »

Trump administration asks intelligence agencies to find out whether China, WHO hid COVID-19 informationTrump administration asks intelligence agencies to find out whether China, WHO hid COVID-19 informationThe White House has ordered intelligence agencies to establish whether China and the WHO initially hid what they knew about the emerging coronavirus pandemic, current and former U.S. officials familiar with the matter tell NBCNews
Read more »

'Delusional': Feds slam Martin Shkreli's attempt to leave prison to find COVID-19 cure'Delusional': Feds slam Martin Shkreli's attempt to leave prison to find COVID-19 cureNEW: Martin Shkreli's request to be freed from prison for three months to research a coronavirus cure was blasted by federal prosecutors as the 'same kind of delusional self-aggrandizing behavior' that got him a lengthy sentence in the first place.
Read more »

On My First Day as a Nurse, I Worked the COVID-19 Floor of a HospitalOn My First Day as a Nurse, I Worked the COVID-19 Floor of a Hospital'On my first day as a nurse, I worked the COVID floor of a busy Bronx hospital.' One NYC nurse shares their story with us:
Read more »



Render Time: 2025-03-12 20:16:47